ESTRELLA IMMUNOPHARMA, INC. (ESLAW) Free cash flow
ESTRELLA IMMUNOPHARMA, INC. (ESLAW) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
No annual history for this metric yet
The company may have no SEC filings (ETF / non-US listing), or the concept is absent from its filings.
← Back to ESLAWSource: SEC XBRL filings · For reference only · Not investment advice
More ESLAW financial trends
ESLAW RevenueESLAW Net incomeESLAW Net marginESLAW Gross profitESLAW Gross marginESLAW Operating incomeESLAW Operating marginESLAW Operating cash flowESLAW Capital expendituresESLAW Return on equityESLAW Stock buybacksESLAW Dividends paidESLAW Total assetsESLAW Total liabilitiesESLAW Shareholders’ equityESLAW overview →